Condition: Adult Congenital Heart Disease · Sponsor: Leiden University Medical Center
This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.
This description comes directly from the study's public registry record.
Anastasia D. Egorova, MD, PhD · +31 71 5262020 · a.egorova@lumc.nl
Always discuss trial participation with your own doctor first.
| Leiden University Medical Center (LUMC) | Leiden, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06969924